XML 76 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Financial Information of Heritage Insurance Holdings, Inc. (Tables)
12 Months Ended
Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Schedule of Condensed Balance Sheets

The following summarizes the major categories of Heritage Insurance Holdings, Inc.’s financial statements:

 

BALANCE SHEET

 

As of December 31,

 

 

 

2018

 

 

2017

 

 

 

(In thousands)

 

ASSETS

 

 

 

 

 

 

 

 

Fixed maturity securities, available for sale, at fair value

 

$

 

 

$

 

Cash and cash equivalents

 

 

13,892

 

 

 

16,249

 

Investment in and advances to subsidiaries

 

 

598,525

 

 

 

584,983

 

Other assets

 

 

3,324

 

 

 

1,294

 

Total Assets

 

$

615,741

 

 

$

602,526

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Other liabilities

 

 

190,408

 

 

 

222,710

 

Total Liabilities

 

$

190,408

 

 

$

222,710

 

Paid-in-capital

 

 

325,295

 

 

 

294,839

 

Treasury stock, at costs, 7,214,797

 

 

(89,185

)

 

 

(87,185

)

Accumulated other comprehensive income

 

 

(6,527

)

 

 

(3,064

)

Retained earnings

 

 

195,750

 

 

 

175,226

 

Total Stockholders' Equity

 

$

425,333

 

 

$

379,816

 

Total Liabilities and Stockholders' Equity

 

$

615,741

 

 

$

602,526

 

Schedule of Condensed Statements of Operations

 

STATEMENT OF OPERATIONS

 

For the Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

 

 

(In thousands, except share and per share amounts)

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Other revenue

 

$

1,858

 

 

$

1,949

 

 

$

1,403

 

Total revenue

 

 

1,858

 

 

 

1,949

 

 

 

1,403

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expense

 

 

19,005

 

 

 

17,792

 

 

 

11,558

 

Amortization of debt issuance cost

 

 

4,623

 

 

 

2,314

 

 

 

41

 

Interest expense, net

 

 

17,277

 

 

 

11,158

 

 

 

321

 

Other non-operating expense, net

 

 

9,791

 

 

 

41,013

 

 

 

 

Total expenses

 

$

50,696

 

 

$

72,277

 

 

$

11,920

 

Loss before income taxes and equity in net income of

   subsidiaries

 

 

(48,838

)

 

 

(70,328

)

 

 

(10,517

)

Benefit from income taxes

 

 

(9,545

)

 

 

(6,120

)

 

 

(2,035

)

Loss before equity in net income of subsidiaries

 

 

(39,293

)

 

 

(64,208

)

 

 

(8,482

)

Equity in net income of subsidiaries

 

 

 

 

 

 

 

 

 

Net loss

 

$

(39,293

)

 

$

(64,208

)

 

$

(8,482

)

Schedule of Condensed Statements of Cash Flows

 

STATEMENT OF CASH FLOW

 

For the Year Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

 

 

(In thousands)

 

Net cash provided by (used in) operating activities

 

$

(21,004

)

 

$

27,154

 

 

$

(6,045

)

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of investment available for sale

 

 

 

 

 

78,213

 

 

 

(77,910

)

Dividends received from subsidiaries

 

 

92,800

 

 

 

57,575

 

 

 

85,096

 

Acquisition of a business

 

 

 

 

 

(210,000

)

 

 

 

Investments and advances to subsidiaries

 

 

(42,200

)

 

 

 

 

 

(74,361

)

Net cash provided by (used in) investing activities

 

 

50,600

 

 

 

(47,058

)

 

 

(73,220

)

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of stock options and warrants

 

 

 

 

 

417

 

 

 

 

Proceeds from issuance of note payable, net of issuance costs

 

 

110,769

 

 

 

114,335

 

 

 

77,910

 

Proceeds from mortgage loan

 

 

 

 

 

12,658

 

 

 

 

Repayment of secured senior notes

 

 

(79,500

)

 

 

 

 

 

 

Mortgage loan payments

 

 

(264

)

 

 

 

 

 

 

Repurchase of convertible notes

 

 

(52,739

)

 

 

 

 

 

 

Excess tax (expense) benefit on stock-based compensation

 

 

 

 

 

 

 

 

(739

)

Shares tendered for income tax withholdings

 

 

(1,839

)

 

 

(1,599

)

 

 

(977

)

Purchase of treasury stock

 

 

(2,000

)

 

 

(61,623

)

 

 

(25,562

)

Dividends

 

 

(6,380

)

 

 

(8,249

)

 

 

(6,806

)

Net cash provided by financing activities

 

 

(31,953

)

 

 

55,939

 

 

 

43,826

 

Increase (decrease) in cash and cash equivalents

 

 

(2,357

)

 

 

8,881

 

 

 

(29,394

)

Cash and cash equivalents, beginning of period

 

 

16,249

 

 

 

7,368

 

 

 

36,762

 

Cash and cash equivalents, end of year

 

$

13,892

 

 

$

16,249

 

 

$

7,368